Redefining Revision
Defiance®
Treat Deeper. Faster. Easier.
Wilmington, DE, June 28, 2023—Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that it closed the acquisition of Novastep®, a subsidiary of Amplitude Surgical SA (Paris: AMPLI), and global developer of clinically proven foot and ankle solutions.
Wilmington, DE, April 11, 2023 - Today, Enovis™ Corporation (NYSE: ENOV), an innovation-driven medical technology company, announced the launch of Enofix™ with Constrictor® Technology, the latest addition to Enovis’ growing suite of foot and ankle products. Enofix™ with Constrictor® Technology is a repair system that demonstrates superior fixation under cyclic loading.1
Dec 4-6 |
Society of Military Orthopaedic Surgeons' Annual Meeting |
Dec 8-9 |
HSS Holiday Knee & Hip Course |
Dec 13-16 |
Current Concepts in Joint Replacement (CCJR) |
Powered by a culture of continuous improvement, extraordinary talent and innovation—we “create better together” by partnering with healthcare professionals. Together, we help patients thrive through an extensive range of products, services and integrated technologies that fuel an active lifestyle.
Individual results may vary.
Neither DJO, LLC nor any of the Enovis companies dispense medical advice. The contents of this website do not constitute medical, legal, or any other type of professional advice. Rather, please consult your healthcare professional for information on the courses of treatment, if any, which may be appropriate for you.
Some of the products advertised on this website may not be licensed in accordance with Canadian law.